Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myocardial reverse remodeling: how far can we rewind?
Patrícia Gonçalves‐Rodrigues, Adelino Leite‐Moreira, Inês Falcão‐Pires
AJP Heart and Circulatory Physiology (2016) Vol. 310, Iss. 11, pp. H1402-H1422
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo‐controlled trial
Michel Komajda, Richard Isnard, Alain Cohen‐Solal, et al.
European Journal of Heart Failure (2017) Vol. 19, Iss. 11, pp. 1495-1503
Open Access | Times Cited: 180
Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3‐dependent manner
Guoliang Meng, Jieqiong Liu, Shangmin Liu, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 8, pp. 1126-1145
Open Access | Times Cited: 115
Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy
Xuejun Wang, Taixing Cui
AJP Heart and Circulatory Physiology (2017) Vol. 313, Iss. 2, pp. H304-H319
Open Access | Times Cited: 75
Impact of diabetes on the predictive value of heart failure biomarkers
Núria Alonso, Josep Lupón, Jaume Barallat, et al.
Cardiovascular Diabetology (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 56
Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
Christian Bär, Shambhabi Chatterjee, Inês Falcão‐Pires, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 11, pp. 1805-1819
Open Access | Times Cited: 48
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg
Daniela Miranda‐Silva, Tânia Lima, Patrícia Rodrigues, et al.
Heart Failure Reviews (2021) Vol. 26, Iss. 3, pp. 453-478
Closed Access | Times Cited: 28
Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
Chris J. Kapelios, Jonathan R. Murrow, Thomas Nührenberg, et al.
Heart Failure Reviews (2019) Vol. 24, Iss. 3, pp. 367-377
Open Access | Times Cited: 32
Use of speckle tracking to assess heart failure with preserved ejection fraction
John B. Hiebert, James L. Vacek, Zubair Shah, et al.
Journal of Cardiology (2019) Vol. 74, Iss. 5, pp. 397-402
Open Access | Times Cited: 28
An updated Lagrangian constrained mixture model of pathological cardiac growth and remodelling
Debao Guan, Xin Zhuan, Xiaoyu Luo, et al.
Acta Biomaterialia (2023) Vol. 166, pp. 375-399
Open Access | Times Cited: 8
Imaging technologies for cardiac fiber and heart failure: a review
Shana R. Watson, James D. Dormer, Baowei Fei
Heart Failure Reviews (2018) Vol. 23, Iss. 2, pp. 273-289
Open Access | Times Cited: 27
Diet-Induced Microbiome’s Impact on Heart Failure: A Double-Edged Sword
Alexandre Rodrigues, Alexandre Gonçalves, Juliana Morais, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1223-1223
Open Access | Times Cited: 7
Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art review
Morris Karmazyn, Xiaohong Tracey Gan
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 11, pp. 2539-2551
Closed Access | Times Cited: 7
Cyclovirobuxine D alleviates aldosterone-induced myocardial hypertrophy by protecting mitochondrial function depending on the mutual regulation of Nrf2-SIRT3
Xueting Wang, Hongkun Wu, Jiangfei An, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115618-115618
Open Access | Times Cited: 7
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
Inês Falcão‐Pires, Ana Filipa Ferreira, Fábio Trindade, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 7, pp. 1454-1479
Open Access | Times Cited: 2
Non-Coding RNAs as Blood-Based Biomarkers in Cardiovascular Disease
Raquel Figuinha Videira, Paula A. da Costa Martins, Inês Falcão‐Pires
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9285-9285
Open Access | Times Cited: 16
RNA sequencing reveals novel LncRNA/mRNAs co-expression network associated with puerarin-mediated inhibition of cardiac hypertrophy in mice
Shan Ye, Weiyan Chen, Caiwen Ou, et al.
PeerJ (2022) Vol. 10, pp. e13144-e13144
Open Access | Times Cited: 10
Therapeutic potentials of modulating autophagy in pathological cardiac hypertrophy
Shenggan Shi, Peidu Jiang
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113967-113967
Open Access | Times Cited: 10
Treatment of the cardiac hypertrophic response and heart failure with ginseng, ginsenosides, and ginseng-related products
Morris Karmazyn, Xiaohong Tracey Gan
Canadian Journal of Physiology and Pharmacology (2017) Vol. 95, Iss. 10, pp. 1170-1176
Open Access | Times Cited: 18
Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease
Alexander T. Mikhailov, Mario Torrado
Heart Failure Reviews (2016) Vol. 21, Iss. 6, pp. 783-794
Open Access | Times Cited: 13
Sex-specific effects of advanced maternal age on cardiovascular function in aged adult rat offspring
Amin Shah, Christy‐Lynn M. Cooke, Raven Kirschenman, et al.
AJP Heart and Circulatory Physiology (2018) Vol. 315, Iss. 6, pp. H1724-H1734
Closed Access | Times Cited: 14
The role of mechanotransduction in heart failure pathobiology—a concise review
Wolfgang A. Krueger, Nicole Bender, Martin Haeusler, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 4, pp. 981-995
Closed Access | Times Cited: 12
Specificities of Myocardial Infarction and Heart Failure in Women
Milica Dekleva, Ana Djordjević, Stefan Zivkovic, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7319-7319
Open Access | Times Cited: 1
Impaired Myocardial Bioenergetics in HFpEF and the Role of Antioxidants
John B. Hiebert, Qiuhua Shen, Amanda R. Thimmesch, et al.
The Open Cardiovascular Medicine Journal (2016) Vol. 10, Iss. 1, pp. 158-162
Open Access | Times Cited: 11
Novel drugs for heart rate control in heart failure
Agata Bielecka‐Dąbrowa, Stephan von Haehling, Jacek Rysz, et al.
Heart Failure Reviews (2018) Vol. 23, Iss. 4, pp. 517-525
Closed Access | Times Cited: 10
The Degree of Cardiac Remodelling before Overload Relief Triggers Different Transcriptome and miRome Signatures during Reverse Remodelling (RR)—Molecular Signature Differ with the Extent of RR
Patrícia Gonçalves‐Rodrigues, Daniela Miranda‐Silva, Xidan Li, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9687-9687
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top